Today, our screeners were at work and below is a list of 4 HealthTech Stocks up over 45% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
Summary: Unicycive Therapeutics Inc. is a clinical stage biotechnology company. It involved in developing therapies for patients with kidney disease. The company's lead drug consist Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. Unicycive Therapeutics Inc. is based in LOS ALTOS, Calif.
Recent UNCY Stock Price (approx 10:00am EST.): $2.09
Previous Close for UNCY Stock: $2.16
Percentage Price Change Past 10 Days for UNCY stock: +327%
|
What is the forecast for UNCY stock? Here are 3rd party ratings for UNCY stock:
|
What’s the sentiment on the street for UNCY stock? Current ratings compiled by TipRanks.com)
|
Click for the UNCY stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
Recent SOPH Stock Price (approx 10:00am EST.): $5.45
Previous Close for SOPH Stock: $5.49
Percentage Price Change Past 10 Days for SOPH stock: +97%
|
What is the forecast for SOPH stock? Here are 3rd party ratings for SOPH stock:
|
What’s the sentiment on the street for SOPH stock? Current ratings compiled by TipRanks.com)
|
Click for the SOPH stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Entrada Therapeutics Inc, TRDA
Summary: Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.
Recent TRDA Stock Price (approx 10:00am EST.): $15.53
Previous Close for TRDA Stock: $14.1
Percentage Price Change Past 10 Days for TRDA stock: +46%
|
What is the forecast for TRDA stock? Here are 3rd party ratings for TRDA stock:
|
What’s the sentiment on the street for TRDA stock? Current ratings compiled by TipRanks.com)
|
Click for the TRDA stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors.
Recent JNCE Stock Price (approx 10:00am EST.): $1.61
Previous Close for JNCE Stock: $1.56
Percentage Price Change Past 10 Days for JNCE stock: +45%
|
What is the forecast for JNCE stock? Here are 3rd party ratings for JNCE stock:
|
What’s the sentiment on the street for JNCE stock? Current ratings compiled by TipRanks.com)
|
Click for the JNCE stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
